[go: up one dir, main page]

CR11755A - Dronedarona para la prevencion de la cardioversion - Google Patents

Dronedarona para la prevencion de la cardioversion

Info

Publication number
CR11755A
CR11755A CR11755A CR11755A CR11755A CR 11755 A CR11755 A CR 11755A CR 11755 A CR11755 A CR 11755A CR 11755 A CR11755 A CR 11755A CR 11755 A CR11755 A CR 11755A
Authority
CR
Costa Rica
Prior art keywords
cardioversion
prevention
dronedarona
dronedarone
medicament
Prior art date
Application number
CR11755A
Other languages
English (en)
Inventor
Christophe Gaudin
Nacéra Hamdani
Davide Radzik
Eickels Martin Van
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39739955&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR11755(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of CR11755A publication Critical patent/CR11755A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Furan Compounds (AREA)
  • Electrotherapy Devices (AREA)

Abstract

La presente invención se refiere al uso de dronedarona para la preparación de un medicamento para uso en la prevención de la cardioversión, en particular la cardioversión eléctrica.
CR11755A 2008-06-10 2010-10-25 Dronedarona para la prevencion de la cardioversion CR11755A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6026008P 2008-06-10 2008-06-10
EP08290532A EP2133075A1 (en) 2008-06-10 2008-06-10 Use of dronedarone for the preparation of a medicament intended for the prevention of cardioversion

Publications (1)

Publication Number Publication Date
CR11755A true CR11755A (es) 2011-01-10

Family

ID=39739955

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11755A CR11755A (es) 2008-06-10 2010-10-25 Dronedarona para la prevencion de la cardioversion

Country Status (25)

Country Link
US (1) US20110166221A1 (es)
EP (2) EP2133075A1 (es)
JP (1) JP2011522875A (es)
KR (1) KR20110026421A (es)
CN (1) CN102056602A (es)
AR (1) AR072070A1 (es)
AU (1) AU2009259008A1 (es)
BR (1) BRPI0915015A2 (es)
CA (1) CA2727210A1 (es)
CL (1) CL2010001421A1 (es)
CO (1) CO6280478A2 (es)
CR (1) CR11755A (es)
DO (1) DOP2010000361A (es)
EA (1) EA201071412A1 (es)
EC (1) ECSP10010661A (es)
IL (1) IL209790A0 (es)
MA (1) MA32461B1 (es)
MX (1) MX2010013700A (es)
NI (1) NI201000212A (es)
PE (1) PE20110066A1 (es)
SV (1) SV2010003753A (es)
TW (1) TW201002314A (es)
UY (1) UY31887A (es)
WO (1) WO2009150534A1 (es)
ZA (1) ZA201009171B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI519298B (zh) 2008-04-17 2016-02-01 賽諾菲 安萬特公司 決奈達隆（ｄｒｏｎｅｄａｒｏｎｅ）於製備用於預防心血管疾病住院或死亡之藥劑之用途
FR2930149B1 (fr) * 2008-04-17 2011-02-18 Sanofi Aventis Association de dronedarone avec au moins un diuretique, son application en therapeutique
EP2116239A1 (en) * 2008-04-29 2009-11-11 Sanofi-Aventis Method for managing the risks associated with an increase in serum creatinine during dronedarone treatment
US8602215B2 (en) 2010-06-30 2013-12-10 Sanofi Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation
WO2013024411A1 (en) 2011-08-12 2013-02-21 Lupin Limited Co-milled formulation of dronedarone
CN104721547A (zh) * 2015-03-14 2015-06-24 包汉雨 一种促进房颤患者复律的中药组合物

Also Published As

Publication number Publication date
MX2010013700A (es) 2011-02-23
CL2010001421A1 (es) 2011-05-13
SV2010003753A (es) 2011-03-15
NI201000212A (es) 2011-04-27
UY31887A (es) 2010-01-29
PE20110066A1 (es) 2011-02-16
AU2009259008A1 (en) 2009-12-17
CA2727210A1 (en) 2009-12-17
IL209790A0 (en) 2011-02-28
KR20110026421A (ko) 2011-03-15
US20110166221A1 (en) 2011-07-07
BRPI0915015A2 (pt) 2015-10-27
CO6280478A2 (es) 2011-05-20
MA32461B1 (fr) 2011-07-03
CN102056602A (zh) 2011-05-11
AR072070A1 (es) 2010-08-04
JP2011522875A (ja) 2011-08-04
EA201071412A1 (ru) 2011-06-30
ECSP10010661A (es) 2011-01-31
DOP2010000361A (es) 2010-12-31
EP2303259A1 (en) 2011-04-06
WO2009150534A1 (en) 2009-12-17
ZA201009171B (en) 2012-03-28
EP2133075A1 (en) 2009-12-16
TW201002314A (en) 2010-01-16

Similar Documents

Publication Publication Date Title
NI201000211A (es) Dronedarona para la prevención de la fibrilación auricular permanente.
MX395271B (es) Composicion farmaceutica.
CO6321189A2 (es) Compuestos de tiazol y oxazol de bencen-sulfonamida
DOP2011000084A (es) Uso de ditiina-tetracarboximidas para combatir hongos fitopatogenos
UY32728A (es) Composición farmacéutica y procedimiento de tratamiento para la anticoncepción de emergencia
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
TW200942524A (en) Novel aminomethyl benzene derivatives
MX2012007098A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
MX2012007161A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
WO2010118866A8 (en) Trehalulose-containing composition, its preparation and use
TW200942530A (en) Pyridine compounds
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
CR11755A (es) Dronedarona para la prevencion de la cardioversion
TN2009000510A1 (en) Extended release formulation of nevirapine
DOP2010000400A (es) 7-sulfanilmetil-,7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos
BR112014014278A2 (pt) composição farmacêutica
BR112012002311A2 (pt) composto, composição farmacêutica, e, uso do composto.
MX2013000539A (es) Nuevas formulaciones de analogos 14-epi de la vitamina d.
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
MX2012007097A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
TR201109158A2 (tr) Eplerenon içeren kolay çözünebilen farmasötik kompozisyon.
MX2013008559A (es) Derivados de leptina.
BR112012033644A2 (pt) tapentadol para uso no tratamento de síndrome do intestino irritável
TN2010000514A1 (en) Dronedarone for the prevention of permanent atrial fibrillation
UA96037C2 (ru) Применение антагониста рецепторов интерлейкина-1 как средства антиалкогольного действия

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)